IDSA Quality Improvement Committee

The charge of the IDSA Quality Improvement Committee (QIC) is as follows:

To promote valid performance measures that IDSA members can implement to improve patient care outcomes in infectious diseases;
To actively participate in and respond to:

The National Quality Forum (NQF) activities and policies as they relate to infectious diseases;
CMS Call for Measures (and engage the CMS Quality Measurement and Health Assessment Group);
The American Medical Association (AMA) Physician Consortium for Performance Improvement measurement activity;
Other organizations involved in quality improvement and performance measurement (Agency for Healthcare Research and Quality, National Committee for Quality Assurance, etc.);
Commercial payer quality improvement initiatives (Bridges to Excellence).

To investigate the feasibility of developing a registry for members to report and compare results on standard measures of patient care and outcomes;
To provide both online and in-person (via IDWeek) educational resources that will inform IDSA members about quality improvement in general and applicable performance measures;
To approach quality measurement of ID clinical care in a manner that promotes the value of ID specialists to the broader health care system.

David Classen, MD - Chair

Joshua Eby, MD

Clare Gentry, MD, MS

Michael Lane, MD, MPH, MSc

John O'Horo, MD, MPH

Theresa Madaline, MD

Casi Wyatt, MD

Ajay Mathur, MD

Jasime Dhindsa, MD

Molade Sarumi, MD

Nimisha Mishra-Shukla, MD

Kathleen Sheridan, DO

David Wheeler, MD, FACP, FIDSA

Susan Bleasdale, MD - Clinical Affairs Committee Liaison

Victoria J. Fraser, MD, FIDSA - Board Liaison

Ann Avery, MD - HIVMA Liaison

Susan Coffin, MD - PIDS Liaison

Thomas Kim - Assigned IDSA Staff